Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 22

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 group infection rotavirus cats pigs antiviral IBV calves piglets mice PEDV rats patients dogs PEMF
2 groups infected iga vaccinated PRRSV mdef201 chickens oocyst sows MHV pigs exposed bats ccov olfactory
3 1 viral calves vaccine PRV ribavirin chicks oocysts TCV resistance TGEV exposure children trazodone MPSL
4 significantly animals antibody vaccination PCV2 mice bronchitis E. KO brain weaned male SARS i.m rats
5 2 virus igm challenge SIV vivo NDV × poults salmonella - hamsters onset biomarkers ONFH
6 control detected igg felv respiratory in vivo birds lambs experiments hepatitis NK 200 cov jejunostomy MU314
7 study disease antibodies feline tnf-α rhuifn-α tracheal profilin litters MHV3 porcine female niv parasite osteonecrosis
8 3 strain serum inactivated swine asmq H120 parvum turkeys susceptible dpi exposed to volunteers migrating 5HT
9 days signs colostrum weeks porcine dose infectious bronchitis virus cryptosporidiosis fetal mouse epidemic ADA rinse macaques pcs
10 compared days ASC dose respiratory syndrome virus doses quails QCDC exp mouse hepatitis virus PED ppm rhesus tacrolimus ALV-J
11 higher cells milk non-vaccinated BAL lethal infectious fecal oocyst pregnancy csa g2b PQ mers‐cov transplantation space
12 treatment clinical BRV kittens BALF MHV‐2 broiler 1.5 gilts liver semen germ-free allergic grafts wistar
13 day RNA cows immunity LPS vitro CR88 cryptosporidium offspring c57bl shedding 3500 human canine density
14 results viral rna responses protected subtype IFN kidney shedding PI macrophages pids mg ISH horses E2
15 7 tissues cattle protection IV DEF201 eggs SAA piglet MHV-JHM S102 toxicity tonsillitis chinese CA2
16 effect inoculation specific virulent reproductive hiltonol chicken coli PEMS cortex diarrhea H. sars-cov TBI neuroepithelium
17 levels observed igg1 median H1N1 survival live hp pregnant routes SDPP IDPN months VSV ALP
18 significant experimentally BCV unvaccinated piglets OK‐432 poultry fecal turkey BALB anti-pedv ferrocene illness IES resting
19 5 isolated bovine neutralising H3N2 RVFV vaccine e. coli CMAH LPAIV bovsdp buprenorphine east HSS NW
20 + coronavirus response minimum hps U27 vaccinated duodenalis IFA H4N6 pig 1500 min cardiopulmonary mucosa
21 4 inoculated RBCV camels lung in vitro variant cryptosporidium parvum weaning T-2 transmissible noted alpacas dehydration wistar rats
22 % high gnotobiotic viraemia ° administered trachea eimeria dam SJL fecal reference A(H7N9 bypass CA1
23 increased p.i iga antibodies transmission syndrome single dose ampv 106 ptov resistant atrophic PR colts oral administration pharyngeal
24 control group detection BVDV challenged influenza mg/kg/day vaccinated groups diarrhoea ncs virus pdcov pullorum AZT convalescent echt
25 30 tract nasal secretions morbidity choleraesuis USPIO MBL C. forming CNS atrophic enteritis exposures onset of presented unsoiled
26 21 post immunoglobulin FECV bronchoalveolar vaccinia quail G. PRNT(80 c3h mice transmissible gastroenteritis virus ELF-EMF d.p.i MARV lacked
27 divided studied propria range fluids interferon B1648 adjuvant hpi cerebral = weights zoonotic complex ca2 cells
28 total investigated bovine rotavirus seronegative fever therapeutic eos dairy pregnant sows balb/cbyj cell 400 carrier ultrafiltration cages
29 blood clinical signs calf PCR lavage tumor AIV c. parvum WT JHM PID rat marv-ang leishmania LDH
30 group 2 associated with secretions virus ifn-α 24 groups diarrhea farrowing C3H RNA behavior a.i cardiopulmonary bypass isozyme
31 < isolation diarrhea FIV PRRS ifn‐α avian g. duodenalis acid pups epidemic diarrhea virus acquisition therapeutics chinese herbs damp-heat
32 group 1 respiratory ELISA fiv-positive lena TP L10H zinc experiment dams nc16845b exposure-related anti-sars herbs decoction
33 parameters primary elisas protective s. choleraesuis SCBLC doa haptoglobin rate i.n genomic smoke HIB motility application
34 observed lymph DX cmt swh1n1 antiviral effect 793/B NTZ fetus reovirus bonov subcutaneous rhesus macaques CB/05 PS
35 showed important titers boosted NA 100 AIV-H9N2 zuernii length i.c OH-FD22 mg/kg/day process rvsv MOB
36 response day nasal vaccinations porpv mouse garlic gain contents KUL01 tcid(50)/ml fields model beagle trend
37 6 shown epizootic cat PMWS cancer hens weight astrovirus cord ge/ml apmvs echinacea anemia OVX
38 lymphocyte nasal SA11 con pcv2-infected H5N1 chick faecal ewes spinal VR-2385 RAM reproductive tract gondii radiodermatitis
39 group 3 outbreaks cell-mediated MVA-VP2 lesions poly dpi isospora FHC encephalomyelitis 9 ada/m3 middle east respiratory syndrome coronavirus slow WSSV
40 infected pathogens rotavirus infection blood H1N2 ifn‐γ broilers cysts exps suppressed naïve ossme herpes engraftment modeling
41 saline experimental infection ETEC clinical cd8+ cells D-USPIO M41 biochemical experiment 3 inoculation intestinal CQ rhinovirus AVI-7288 poly(i
42 infection absence WD fipv pmws-affected EV71 pvax1 excretion RVF spinal cord neonatal h. pullorum demyelinating myeloperoxidase cage
43 untreated study intestinal ccv PID activity NIBV body PES salmonella infection GIII.2 PR+PQ ferrets zebov-makona 53
44 35 persistently CC mycoplasma -α model layers CFU TGEV MHV-S N/C test anti-measles up-regulated B(4
45 effects of proteins VLP peritonitis PRRSV-1 treatment L10L halofuginone neutralizing dissemination vac-im-2b drug NT animals sandwich
46 control groups common oral inoculation protective effect faecium 8-cl-7-dzguo embryos HN ml dieldrin naïve pigs mg/ml prospective administration innate
47 96 levels isotype-specific vaccinated group tcid50/ml transplanted rdev-n HL PEDV C(3)H states body-weight hcov-nl63 oral rat
48 ifn-γ viral antigen isotypes vaccinates group iv MS broiler chickens isotonic gestation cerebral cortex coinfected fish peripubertal 9 A(4
49 baseline 5 PGA control belgium pfu/mouse caninum treated avirulent balb mice piglets deficits % week C57BL/6J
50 consisted serum reinfected doses prrsv antiviral activity ORT intestinal CY clodronate I.N. kv/m zoonotic transmission neurotoxicity steroid-induced